Skip to main content
Top

Drugs

Issue 5/2016

Content (9 Articles)

Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere?

  • Current Opinion

Sean G. Kelly, Amesika N. Nyaku, Babafemi O. Taiwo

The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions

  • Therapy in Practice

Paolo Curatolo, Marit Bjørnvold, Patricia E. Dill, José Carlos Ferreira, Martha Feucht, Christoph Hertzberg, Anna Jansen, Sergiusz Jóźwiak, J. Christopher Kingswood, Katarzyna Kotulska, Alfons Macaya, Romina Moavero, Rima Nabbout, Bernard A. Zonnenberg

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

  • Review Article

George G. Zhanel, Doris Cheung, Heather Adam, Sheryl Zelenitsky, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew Walkty, Alfred S. Gin, Daryl J. Hoban, James A. Karlowsky

Antipsychotic Management of Schizoaffective Disorder: A Review

  • Review Article

Jean-Pierre Lindenmayer, Amandeep Kaur

Elbasvir/Grazoprevir: First Global Approval

  • AdisInsight Report

Gillian M. Keating

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images